Table 2 Clinical features of CF patients
From: The association of fecal calprotectin and respiratory exacerbation in cystic fibrosis patients
Clinical manifestation | Frequency (percentage) of the first visit | Frequency (percentage) in two weeks later | Frequency (percentage) of relapse with symptoms |
|---|---|---|---|
Cough | (80) 24 | (36.7) 11 | (90.0) 27 |
Hemoptysis (severe (> 250 ml/day) | (6.7) 2 | (6.7) 2 | (16.7) 5 |
Dyspnea | (50) 15 | (13.3) 4 | (46.7) 14 |
Increased sputum | (60) 18 | (20) 6 | (56.7) 17 |
Change the color of sputum | (26.7) 8 | (20) 6 | (16.7) 5 |
Fever | (6.7) 2 | (6.7) 2 | _ |
Weight loss | (20) 6 | (6.7) 2 | (3.3) 1 |
Anemia | (3.3) 1 | _ | _ |
Weakness and lethargy | (10) 3 | (3.3) 1 | (3.3) 1 |
failure to weight gain / weight loss | (20) 6 | (6.7) 2 | (10) 3 |
Other manifestations | (38.8) 12 | _ | _ |